Prognostic impact of KMT2E transcript levels on outcome of patients with acute promyelocytic leukaemia treated with all-trans retinoic acid and anthracycline-based chemotherapy: an International Consortium on Acute Promyelocytic Leukaemia study.

Cite this paper

@article{LucenaAraujo2014PrognosticIO, title={Prognostic impact of KMT2E transcript levels on outcome of patients with acute promyelocytic leukaemia treated with all-trans retinoic acid and anthracycline-based chemotherapy: an International Consortium on Acute Promyelocytic Leukaemia study.}, author={Antonio R Lucena-Araujo and Haesook T Kim and Rafael Henriques J{\'a}como and Raul Antonio M. Melo and Rosane Isabel Bittencourt and Ricardo Pasquini and K{\'a}tia B{\'o}rgia Barbosa Pagnano and Evandro Maranh{\~a}o Fagundes and Maria de Lourdes Chauffaille and Carlos S{\'e}rgio Chiattone and Ana S{\'i}lvia Gouveia Lima and Hau C . Kwaan and Robert E. Gallagher and Charlotte Marie Niemeyer and Stanley L. Schrier and Martin S. Tallman and David J Grimwade and Arnold Ganser and Nancy Berliner and Raul C. Ribeiro and Francesco Lo-Coco and Bob L{\"{o}wenberg and Miguel {\'A}ngel Sanz and Eduardo M Rego}, journal={British journal of haematology}, year={2014}, volume={166 4}, pages={540-9} }